Concepedia

Tissue Biomarker Validation

Tissue Biomarker Validation is the systematic process of confirming the reliability, specificity, and clinical relevance of molecular or cellular indicators within tissue specimens to ensure their accurate use in disease diagnosis, prognosis, or therapeutic response prediction.

32

Publications

1.5K

Citations

339

Authors

123

Institutions

Publications per year

2017–2026

12

Parents

Publications

32

Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology

Torsten O. Nielsen, Forrest D. Hsu, John X. OʼConnell et al. · American Journal Of Pathology · 2003 · 140 citations · Full text

, , +15

Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin

Shai Rosenwald, Shlomit Gilad, Sima Benjamin et al. · Modern Pathology · 2010 · 133 citations · Full text

, , +16

New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice

John B. Kisiel, Massimo Raimondo, William R. Taylor et al. · Clinical Cancer Research · 2015 · 131 citations · Full text

, , +16

RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast

Celina G. Kleer, Kent A. Griffith, Michael S. Sabel et al. · Breast Cancer Research and Treatment · 2005 · 118 citations · Full text

, , +14

Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

Bradley W. Anderson, Yun‐Suhk Suh, Boram Choi et al. · Clinical Cancer Research · 2018 · 99 citations · Full text

, , +17

1–5 of 32

Authors

339

  1. DA
    David A. Ahlquist

    Mayo Clinic, United States

    2 publications · 230 citations

    2

    h-index

  2. TC
    Tracy C. Yab

    Mayo Clinic, United States

    2 publications · 230 citations

    2

    h-index

  3. WR
    William R. Taylor

    Mayo Clinic, United States

    2 publications · 230 citations

    2

    h-index

  4. TC
    Thomas C. Smyrk

    Mayo Clinic, United States

    2 publications · 230 citations

    2

    h-index

  5. TK
    Tadashi Kondo

    National Cancer Research Institute, United Kingdom

    2 publications · 52 citations

    2

    h-index

1–5 of 339

Institutions

123

  1. Stanford University

    Stanford, United States

    3 h-index

    19 publications

    1.3K citations

  2. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    2 h-index

    9 publications

    180 citations

  3. Mayo Clinic

    Rochester, United States

    2 h-index

    26 publications

    3K citations

  4. University of Copenhagen

    Copenhagen, Denmark

    2 h-index

    5 publications

    213 citations

  5. University of British Columbia

    Vancouver, Canada

    2 h-index

    8 publications

    775 citations

  6. National Cancer Institute

    Bethesda, United States

    2 h-index

    3 publications

    94 citations

  7. Mayo Clinic in Florida

    Jacksonville, United States

    2 h-index

    26 publications

    3K citations

  8. Palo Alto University

    Palo Alto, United States

    2 h-index

    11 publications

    405 citations

1–8 of 123

Venues

  1. Clinical Cancer Research

    3 publications · 306 citations

    3

    h-index

  2. PLoS ONE

    2 publications · 34 citations

    2

    h-index

  3. Journal of Proteomics

    2 publications · 52 citations

    2

    h-index

  4. Cancers

    2 publications · 51 citations

    2

    h-index

  5. Cancer Science

    1 publications · 90 citations

    1

    h-index

1–5